NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?

Shilpa Gupta; Ashish M. Kamat

doi:10.1038/s41585-020-0357-1

NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?

Shilpa Gupta, Ashish M. Kamat

Urology

Research output: Contribution to journal › Comment/debate › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	491-492
Number of pages	2
Journal	Nature Reviews Urology
Volume	17
Issue number	9
DOIs	https://doi.org/10.1038/s41585-020-0357-1
State	Published - Sep 1 2020

ASJC Scopus subject areas

Urology

Access to Document

10.1038/s41585-020-0357-1

Cite this

@article{e328a9f7938248b9a029212f8ddfff8d,

title = "NICE{\textquoteright}s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?",

author = "Shilpa Gupta and Kamat, {Ashish M.}",

year = "2020",

month = sep,

day = "1",

doi = "10.1038/s41585-020-0357-1",

language = "English (US)",

volume = "17",

pages = "491--492",

journal = "Nature Reviews Urology",

issn = "1759-4812",

publisher = "Nature Publishing Group",

number = "9",

}

TY - JOUR

T1 - NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma

T2 - is there a greater good?

AU - Gupta, Shilpa

AU - Kamat, Ashish M.

PY - 2020/9/1

Y1 - 2020/9/1

UR - http://www.scopus.com/inward/record.url?scp=85087611616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85087611616&partnerID=8YFLogxK

U2 - 10.1038/s41585-020-0357-1

DO - 10.1038/s41585-020-0357-1

M3 - Comment/debate

C2 - 32632305

AN - SCOPUS:85087611616

SN - 1759-4812

VL - 17

SP - 491

EP - 492

JO - Nature Reviews Urology

JF - Nature Reviews Urology

IS - 9

ER -

NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this